Results 111 to 120 of about 21,745 (193)

Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease. [PDF]

open access: yesAm J Clin Dermatol
Yan A   +9 more
europepmc   +1 more source

Drug Eruptions

open access: yesInternational Journal of Clinical Practice, 1968
openaire   +2 more sources

Adverse Cutaneous Drug Eruptions: Review of Immunology, Pathogenesis, and Pharmacogenomics With Focus on HIV and TEN

open access: yes, 2019
Purpose: Immunologic principles behind antigen presentation inform the pathophysiologic basis of adverse cutaneous drug eruptions (ACDEs). We hypothesize that HIV predisposes to Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN), a severe ...
Guerra, Ricardo
core  

The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions. [PDF]

open access: yesWorld Allergy Organ J
James F   +54 more
europepmc   +1 more source

Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. [PDF]

open access: yesJ Am Acad Dermatol, 2018
Phillips GS   +11 more
europepmc   +1 more source

Autoimmune sequelae in severe drug eruptions [PDF]

open access: yesClin Transl Allergy, 2014
Aoyama Y   +7 more
europepmc   +1 more source

Variants of Fixed Drug Eruptions Following Covid-19 Vaccination: A Series of Three Cases.

open access: yesIndian J Dermatol
Saraswat N   +4 more
europepmc   +1 more source

Fixed-drug Eruptions: What can we Learn from a Case Series?

open access: yesIndian J Dermatol, 2018
Jhaj R   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy